Agile Therapeutics (AGRX)
(Delayed Data from OTC)
$1.47 USD
0.00 (0.00%)
Updated Aug 2, 2024 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For AGRX
-
Agile Therapeutics: Q1 Earnings Snapshot
-
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Agile Therapeutics: Q4 Earnings Snapshot
-
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
-
Agile Therapeutics: Q3 Earnings Snapshot
-
Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
-
Agile Therapeutics: Q2 Earnings Snapshot
-
Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
-
Agile Therapeutics: Q1 Earnings Snapshot
-
Agile Therapeutics Reports First Quarter 2023 Financial Results And Provides Corporate Update
-
Agile Therapeutics: Q4 Earnings Snapshot
-
Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update
-
Agile Therapeutics: Q3 Earnings Snapshot
-
Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
Agile Therapeutics: Q2 Earnings Snapshot
-
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
Agile Therapeutics (AGRX) Reports Q4 Loss, Misses Revenue Estimates
-
Agile Therapeutics (AGRX) Reports Q3 Loss, Lags Revenue Estimates
-
Agile Therapeutics (AGRX) Reports Q2 Loss, Lags Revenue Estimates
-
Agile Therapeutics (AGRX) Reports Q1 Loss, Lags Revenue Estimates
-
Agile Therapeutics (AGRX) Reports Q4 Loss, Misses Revenue Estimates
-
Can Agile Therapeutics (AGRX) Run Higher on Strong Earnings Estimate Revisions?